On May 24, 2021, the World Health Organization (WHO) and the Swiss Confederation signed a Memorandum of Understanding…
On May 22, 2021, Moderna and Samsung Biologics announced a Manufacturing Services and Supply Agreement in which Samsung…
On May 22, 2021, Novavax announced the signing of a non-binding memorandum of understanding (MoU) with the Ministry…
On May 21, 2021, GlaxoSmithKline and Vir Biotechnology announced that the European Medicines Agency’s (EMA) Committee for Human Medicinal…
On May 21, 2021, AstraZeneca announced that it had been granted a special approval for emergency use in…
On May 21, 2021, world leaders the Global Health Summit adopted an agenda to overcome the COVID-19 pandemic,…
On May 21, 2021, Gavi, the Vaccine Alliance, that it had signed an advance purchase agreement with Johnson…
On May 21, 2021, Moderna announced that the Ministry of Health, Labour and Welfare (MHLW) of Japan granted…
On May 21, 2021, Novavax announced that the full results from the Phase 3, randomized, observer-blinded, placebo-controlled trial…
On May 21, 2021, Novavax announced participation in a mix-and-match (vaccine interchangeability) COVID-19 vaccine booster trial that led…
On May 20, 2021, Merck announced V114, the company’s investigational 15-valent pneumococcal conjugate vaccine, met its primary immunogenicity…
On May 20, 2021, XPhyto announced announced it had commenced a pilot project with its rapid COVID-19 PCR…
On May 20, 2021, Pfizer and BioNTech announced a new agreement with the European Commission (EC) to supply…
On May 20, 2021, Pfizer and BioNTech announced an agreement with Turkey’s Ministry of Health to supply 60…
On May 19, 2021, APEIRON Biologics announced the next development steps for APN01 (alunacedase alfa) for the treatment…
On May 17, 2021, Sanofi and GSK reported that their adjuvanted recombinant COVID-19 vaccine candidate achieved strong rates…
On May 17, 2021, Oxford University and Oracle have created a Global Pathogen Analysis System (GPAS) combining Oxford’s…
On May 13, 2021, University of Oxford researchers reported that Com-COV study data comparing mixed dosing schedules of…
On May 12, 2021, Moderna announced a new supply agreement with the government of Australia for 25 million…
On May 12, 2021, InBios announced that it received Emergency Use Authorization (EUA) from the U.S. Food and…
On May 10, 2021, Inovio Pharma announced positive safety, tolerability and immunogenicity data from its placebo-controlled and blinded…
On May 10, 2021, Altimmune announced positive results from a preclinical study of AdCOVID in a SARS-CoV-2 challenge…
On May 10, 2021, Novavax announced data from a preclinical study of the company’s combination quadrivalent seasonal flu…
On May 7, 2021, GlaxoSmithKline and Vir Biotechnology announced that the European Medicines Agency (EMA) has started a…
On May 6, 2021, Moderna announced a new supply agreement with the Swiss Federal Government for 7 million…
On May 6, 2021, Novavax announced that it had finalized an advance purchase agreement (APA) with Gavi, the…
On May 6, 2021, Pfizer announced the signing of a Memorandum of Understanding (MoU) with the International Olympic…
On May 6, 2021, Trevena announced that TRV027, the Company’s novel AT1 receptor selective agonist, had been selected…
On May 5, 2021, the World Health Organization (WHO) and the Federal Republic of Germany announced a new…
On May 5, 2021, Novavax announced the publication of results from the initial primary analysis of a Phase…